Egetis Therapeutics AB (publ) (FRA:P0F)
Germany
· Delayed Price · Currency is EUR 0.413
+0.012 (3.12%)
At close: Dec 5, 2025
Egetis Therapeutics AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -333.3 | -343.6 | -326.9 | -193.8 | -104.5 | -178.02 | Upgrade
|
| Depreciation & Amortization | 27.1 | 3.5 | 3.6 | 2.7 | 2.5 | 0.4 | Upgrade
|
| Stock-Based Compensation | 14.7 | 14.7 | 8 | 8.8 | 1.2 | 0.56 | Upgrade
|
| Other Operating Activities | 6.5 | 8.9 | 6 | -2.1 | -1.1 | 0.38 | Upgrade
|
| Change in Accounts Receivable | -18.2 | 13.4 | -22.9 | -10.7 | 3.1 | 16.43 | Upgrade
|
| Change in Other Net Operating Assets | 75.4 | 75.2 | 53.8 | 21.6 | -31.3 | 25.62 | Upgrade
|
| Operating Cash Flow | -227.8 | -227.9 | -278.4 | -173.5 | -130.1 | -134.64 | Upgrade
|
| Capital Expenditures | -1.5 | - | - | - | -0.2 | -0.02 | Upgrade
|
| Cash Acquisitions | -2.5 | -1.2 | - | -1.7 | -5 | -59.52 | Upgrade
|
| Investment in Securities | - | - | - | - | -0.8 | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0 | Upgrade
|
| Investing Cash Flow | -4 | -1.2 | - | -1.7 | -6 | -59.54 | Upgrade
|
| Long-Term Debt Issued | - | - | 108.8 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -10.2 | -5.6 | -9.1 | -8.9 | -0.22 | Upgrade
|
| Net Debt Issued (Repaid) | -32 | -10.2 | 103.2 | -9.1 | -8.9 | -0.22 | Upgrade
|
| Issuance of Common Stock | 301.5 | 301.5 | 381.9 | 177.4 | - | 250.75 | Upgrade
|
| Repurchase of Common Stock | -1.5 | -1.5 | - | - | - | - | Upgrade
|
| Other Financing Activities | -18.9 | -18.9 | -26.2 | -12.6 | - | -22.13 | Upgrade
|
| Financing Cash Flow | 249.1 | 270.9 | 458.9 | 155.7 | -8.9 | 228.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.7 | 5.8 | -4.8 | 3.2 | 1.1 | -1.47 | Upgrade
|
| Net Cash Flow | 15.7 | 47.6 | 175.7 | -16.3 | -143.9 | 32.75 | Upgrade
|
| Free Cash Flow | -229.3 | -227.9 | -278.4 | -173.5 | -130.3 | -134.66 | Upgrade
|
| Free Cash Flow Margin | -413.90% | -494.36% | -483.33% | -767.70% | -341.10% | -331.18% | Upgrade
|
| Free Cash Flow Per Share | -0.64 | -0.73 | -1.07 | -0.89 | -0.72 | -2.00 | Upgrade
|
| Cash Interest Paid | 8.5 | 8.5 | 4.1 | 0.1 | - | 0 | Upgrade
|
| Cash Income Tax Paid | 0.3 | 0.3 | 0.1 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -110.14 | -105.33 | -159.79 | -112.39 | -90.55 | -62.98 | Upgrade
|
| Unlevered Free Cash Flow | -100.51 | -94.33 | -157.16 | -112.33 | -90.43 | -62.98 | Upgrade
|
| Change in Working Capital | 57.2 | 88.6 | 30.9 | 10.9 | -28.2 | 42.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.